Physician profile
Corazon A Guerra
NPI 1659326437
$2,730.80
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,888 · 2020: $394 · 2021: $369 · 2022: $47.63 · 2023: $32.60.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $32.60.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $32.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $349.14 | 2019-2023 | Rexulti |
| Teva Pharmaceuticals USA, INC. | $284.35 | 2019-2021 | |
| Allergan, INC. | $280.26 | 2019-2020 | |
| Validus Pharmaceuticals LLC | $273.80 | 2019-2021 | |
| Neurocrine Biosciences, INC. | $219.05 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $169.68 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $168.81 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $139.99 | 2019-2021 | |
| Jazz Pharmaceuticals INC. | $138.22 | 2019 | |
| Amarin Pharma, INC. | $125.00 | 2020 | |
| Bausch Health US, LLC | $87.46 | 2019-2020 | |
| Abbvie INC. | $82.81 | 2021 | |
| Tactile Systems Technology INC | $79.73 | 2019 | |
| Shire North American Group INC | $71.43 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $67.07 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $61.93 | 2021 | |
| Ironshore Pharmaceuticals INC. | $58.13 | 2019 | |
| Vanda Pharmaceuticals INC. | $54.10 | 2019-2020 | |
| Neuronetics, INC. | $19.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Corazon Guerra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.